New Paediatric Endocrinology clinics start in Hyderabad, Karachi
The Aga Khan University will be starting new Pediatric Endocrinology clinics at Karimabad in Karachi and at the Aga Khan Maternal & Child Centre in Hyderabad from the last week of September 2023 and start of October.
Dr Fozia Memon and Dr Muzna Arif will be running the clinics. Patients can make an initial in-person visit at Hyderabad and follow up there online (with the teleclinic) direct with the main AKU campus. The Karimabad clinic will be in-person.
Dr Fozia Memon and Dr Muzna each have an MBBS, FCPS (Paediatrics) and fellowships in Paediatric Endocrinology from Aga Khan University.
Timings: 10am to 2pm
Alternate Fridays physical and teleclinic services
Pediatric endocrinology is a specialized field in pediatric care that focuses on the diagnosis and treatment of hormonal disorders in children and adolescents. This field is essential for addressing diseases and conditions that can have a significant impact on a child's growth, development, and overall health.
Conditions commonly treated by pediatric endocrinologists include diabetes, growth disorders, thyroid disorders, adrenal gland disorders, puberty-related issues, and various rare genetic conditions affecting hormone production or function.
The aim of this clinical and teleclinic service is to bridge the gap in healthcare access for pediatric endocrine patients who face difficulties in reaching specialists.
The following are a few conditions in which consultation with a pediatric endocrinologist may be helpful.
- Growth disorders
- Disorders related to androgen excess
- Delayed or early puberty
- Disorders related to thyroid (hypothyroidism, hyperthyroidism, thyroid nodule)
- Type 1 and type 2 diabetes in children
- Disorders related to bone (rickets, osteoporosis)
- Disorders related to parathyroid glands
- Hypoglycemia
- Congenital adrenal hyperplasia
- Adrenal insufficiency
- Obesity (overweight)
- Polycystic ovarian syndrome
- Hypopituitarism
- Endocrine surveillance for thalassemia patients and post-cancer treatment surveillance
